{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:17:08Z","timestamp":1792163828838,"version":"4.4.0"},"publisher-location":"Chichester, UK","reference-count":48,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd006628.pub2","type":"reference-entry","created":{"date-parts":[[2010,1,18]],"date-time":"2010-01-18T19:47:59Z","timestamp":1263844079000},"source":"Crossref","is-referenced-by-count":13,"title":["Zotepine versus other atypical antipsychotics for schizophrenia"],"prefix":"10.1002","author":[{"given":"Katja","family":"Komossa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rummel-Kluge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Hunger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Kissling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,1,20]]},"reference":[{"key":"10.1002\/14651858.CD006628.pub2-BIB1|cit1","series-title":"Proceedings of the12th World Congress of Psychiatry; 2002 Aug 24-29; Yokohama, Japan","article-title":"A randomized, single-blind study to evaluate the antipsychotic effect and safety of clozapine versus switching to zotepine in schizophrenic patients","author":"Chiu","year":"2002"},{"issue":"4","key":"10.1002\/14651858.CD006628.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1016\/S0924-977X(03)92042-6","article-title":"Switching from clozapine to zotepine in schizophrenic patients: a randomized, single-blind controlled study","volume":"13","author":"Lin","year":"2003","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD006628.pub2-BIB3|cit3","first-page":"S500","article-title":"Long-term outcome of switching from clozapine to zotepine in refractory schizophrenia: a 2-year follow-up study","volume":"15","author":"Lin","year":"2005","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD006628.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-2007-979481","article-title":"Improvement of cognitive function in schizophrenic patients receiving clozapine or zotepine: Results from a double-blind study","volume":"30","author":"Meyer-Lindenberg","year":"1997","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD006628.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0920-9964(01)00322-X","article-title":"Effect of zotepine, olanzapine and risperidone on hostility in schizophrenic patients","volume":"57","author":"Briken","year":"2002","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006628.pub2-BIB6|cit6","first-page":"179","article-title":"Zotepine versus clozapine: A comparison of the impact on the cognitive dysfunction syndrome in schizophrenia (a double blind trial)","volume":"28","author":"Gallhofer","year":"1995","journal-title":"Pharmacopsychiatry"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD006628.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"S410","DOI":"10.1016\/S0924-977X(06)70513-2","article-title":"Remission of tardive dyskinesia following the switch from clozapine to zotepine: 2-year follow-up","volume":"16","author":"Lin","year":"2006","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006628.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-2004-832683","article-title":"Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: A randomised double-blind multicenter trial","volume":"37","author":"M\u00f6ller","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD006628.pub2-BIB9|cit9","series-title":"Proceedings of the 11th World Congress of Psychiatry; 1999 Aug 6-11; Hamburg, Germany","article-title":"A prospective clinical comparative-study of four atypical antipsychotic agents in the treatment of schizophrenia","author":"Perro","year":"1999"},{"key":"10.1002\/14651858.CD006628.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecing skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006628.pub2-BIB11|cit11","first-page":"1","volume-title":"Practice guidelines for the treatment of patients with schizophrenia","year":"2004"},{"key":"10.1002\/14651858.CD006628.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0893-133X(97)00112-7","article-title":"Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence","volume":"18","author":"Arnt","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006628.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD006628.pub2-BIB14|cit14","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD006628.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM199403103301006","article-title":"Schizophrenia","volume":"330","author":"Carpenter","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006628.pub2-BIB16|cit16","series-title":"Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28th; Cape Town, South Africa","article-title":"Issues in the selection for meta-analyses of binary data","author":"Deeks","year":"2000"},{"issue":"4","key":"10.1002\/14651858.CD006628.pub2-BIB17|cit17","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001948.pub2","article-title":"Zotepine for schizophrenia","author":"DeSilva","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006628.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD006628.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006628.pub2-BIB20|cit20","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001359.pub2","article-title":"Olanzapine for schizophrenia","author":"Duggan","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD006628.pub2-BIB21|cit21","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004578.pub3","article-title":"Aripiprazole for schizophrenia","author":"El-Sayeh","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006628.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006628.pub2-BIB23|cit23","volume-title":"Treatment guidelines for schizophrenia","author":"Gaebel","year":"2006"},{"key":"10.1002\/14651858.CD006628.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD006628.pub2-BIB25|cit25","doi-asserted-by":"crossref","unstructured":"Guy U ECDEU assessment manual for psychopharmacology National Institute of Mental Health 1976","DOI":"10.1037\/e591322011-001"},{"key":"10.1002\/14651858.CD006628.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1176\/appi.ajp.163.2.185","article-title":"Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine","volume":"163","author":"Heres","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006628.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006628.pub2-BIB28|cit28","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008] The Cochrane Collaboration. Available from www.cochrane-handbook.org 2008","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD006628.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on quality of life","volume":"63","author":"Jones","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006628.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment of treatment-resistant schizophrenia: a double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006628.pub2-BIB31|cit31","first-page":"585","article-title":"Treatment programme and long term outcome in chronic schizophrenia","volume":"46","author":"Kane","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD006628.pub2-BIB32|cit32","volume-title":"Positive and negative syndrome scale (PANSS) manual","author":"Kay","year":"1986"},{"key":"10.1002\/14651858.CD006628.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006628.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of Brief Psychiatric Rating Scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006628.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF02245006","article-title":"Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors","volume":"112","author":"Leysen","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD006628.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Liebermann","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006628.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales - a major source of bias in randomised controlled trials of treatments for schizophrenia?","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006628.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00127-004-0762-4","article-title":"Schizophrenia and employment - a review","volume":"39","author":"Marvaha","year":"2004","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"key":"10.1002\/14651858.CD006628.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT Statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006628.pub2-BIB40|cit40","first-page":"329","article-title":"New assessment of atypical antipsychotics","volume":"71","author":"M\u00f6ller","year":"2000","journal-title":"Nervenarzt"},{"key":"10.1002\/14651858.CD006628.pub2-BIB41|cit41","first-page":"123","article-title":"Zotepine: preclinical tests predict antipsychotic efficacy and an atypical profile","volume":"32","author":"Needham","year":"1996","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD006628.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD006628.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0022-3565(25)38596-4","article-title":"Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors","volume":"268","author":"Roth","year":"1994","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1002\/14651858.CD006628.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2008.04.011","article-title":"Schizophrenia, \"Just the facts\" What we know in 2008. 2. Epidemiology and etiology","volume":"102","author":"Tandon","year":"2008","journal-title":"Schizophrenia research"},{"key":"10.1002\/14651858.CD006628.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archpsyc.1978.01770260031002","article-title":"Suicide in schizophrenics, manics, depressives, and surgical controls: a comparison with general population suicide mortality","volume":"35","author":"Tsuang","year":"1978","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD006628.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD006628.pub2-BIB47|cit47","unstructured":"WHO Mental Health: New Understanding, New Hope The World Health report 2001"},{"issue":"2","key":"10.1002\/14651858.CD006628.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1176\/appi.ajp.2008.08030368","article-title":"A meta-Analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia","volume":"166","author":"Leucht","year":"2009","journal-title":"American Journal of Psychiatry"}],"updated-by":[{"DOI":"10.1002\/14651858.cd006628.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,10,6]],"date-time":"2010-10-06T00:00:00Z","timestamp":1286323200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD006628.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T20:47:41Z","timestamp":1739738861000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006628.pub2"}},"subtitle":[],"editor":[{"given":"Katja","family":"Komossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,1,20]]},"references-count":48,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006628.pub2","relation":{},"subject":[],"published":{"date-parts":[[2010,1,20]]}}}